Cargando…
Optimal therapy for adolescents and young adults with acute lymphoblastic leukemia-current perspectives
Adolescents and young adults (AYA) with acute lymphoblastic leukemia (ALL) have worse prognosis than children. Differing biology of ALL may account for some of this disparity in outcome, with AYA patients having far lower incidence of good risk cytogenetic abnormalities, and higher proportion of pat...
Autor principal: | Lee, Jae Wook |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Society of Hematology; Korean Society of Blood and Marrow Transplantation; Korean Society of Pediatric Hematology-Oncology; Korean Society on Thrombosis and Hemostasis
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7386896/ https://www.ncbi.nlm.nih.gov/pubmed/32719173 http://dx.doi.org/10.5045/br.2020.S005 |
Ejemplares similares
-
Treatment of Adolescent and Young Adults with Acute Lymphoblastic Leukemia
por: Ribera, Josep-Maria, et al.
Publicado: (2014) -
Practical guidance for the management of acute lymphoblastic leukemia
in the adolescent and young adult population
por: Carobolante, Francesca, et al.
Publicado: (2020) -
The Evolution of Chimeric Antigen Receptor T-Cell Therapy in Children, Adolescents and Young Adults with Acute Lymphoblastic Leukemia
por: Ragoonanan, Dristhi, et al.
Publicado: (2022) -
Asparaginase in the Treatment of Acute Lymphoblastic Leukemia in Adults: Current Evidence and Place in Therapy
por: Juluri, Krishna R, et al.
Publicado: (2022) -
Late Effects in Survivors of Adolescent and Young Adult Acute Lymphoblastic Leukemia
por: Muffly, Lori, et al.
Publicado: (2020)